the recent discovery that several autoimmune diseases , such as myasthenia gravis , are the result of an immunopharmacological block at receptor sites , together with several observations of immunological disorders in parkinson 's disease and schizophrenia , suggests the possibility that certain types of parkinson 's disease and schizophrenia might be the consequence of an autoimmune blockade of striatal or limbic dopamine-receptors , respectively .
C0004364
autoimmune diseases
C0026896
myasthenia gravis